FeiginVLBraininMNorrvingB, et al. World Stroke Organization: global stroke fact sheet 2025. Int J Stroke2025; 20: 132–144.
2.
LippiGSanchis-GomarFCervellinG.Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke2021; 16: 217–221.
3.
SposatoLACameronACJohansenMC, et al. Ischemic stroke prevention in patients with atrial fibrillation and a recent ischemic stroke, TIA, or intracranial hemorrhage: a World Stroke Organization (WSO) scientific statement. Int J Stroke2025; 20: 385–400.
4.
BestJGArramLAhmedN, et al. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): protocol for a randomized controlled trial. Int J Stroke2022; 17: 583–589.
5.
WerringDJDehbiHMAhmedN, et al. Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial. Lancet2024; 404: 1731–1741.
6.
FlorentinMSagrisDTasoudisP, et al. Detection of atrial fibrillation after stroke due to large or small vessel disease: systematic review and meta-analysis. Int J Stroke2025; 20: 401–410.
7.
ThakurMAlsinbiliAChattopadhyayRWarburtonEAKhadjooiKInduruwaI.Identifying the optimal time period for detection of atrial fibrillation after ischaemic stroke and TIA: an updated systematic review and meta-analysis of randomized control trials. Int J Stroke2024; 19: 499–505.
8.
YuCCPengYQLinC, et al. ECG-based machine learning model for AF identification in patients with first ischemic stroke. Int J Stroke2025; 20: 411–418.
9.
HarbisonJMcCormackJBrychO, et al. Anticoagulation usage and thrombolytic therapy in subjects with atrial fibrillation associated ischaemic stroke. Int J Stroke2025; 20: 419–425.
10.
Mota TellesJPCenciGIMarinheiroG, et al. Anticoagulation strategy for patients presenting with ischemic strokes while using a direct oral anticoagulant: a systematic review and meta-analysis. Int J Stroke2025; 20: 42–52.
